CHARLES SCHWAB INVESTMENT MANAGEMENT INC – Regeneron Pharmaceuticals, Inc. Transaction History
CHARLES SCHWAB INVESTMENT MANAGEMENT INC portfolio value:
$394.72M
portfolio value
CHARLES SCHWAB INVESTMENT MANAGEMENT INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.45% | 2.54K shares | 57.50M | $688.87 | 573.00K |
| Q2 2022 | share | Increase | +1.48% | 8.32K shares | -55.39M | $591.13 | 570.46K |
| Q1 2022 | share | Increase | +1.05% | 5.84K shares | 41.29M | $698.42 | 562.13K |
| Q4 2021 | share | Increase | +5.05% | 26.76K shares | 30.85M | $642.51 | 556.29K |
| Q3 2021 | share | Increase | +4.88% | 24.64K shares | 38.46M | $605.18 | 529.52K |
| Q2 2021 | share | Increase | +1.02% | 5.09K shares | 45.52M | $558.54 | 504.88K |
| Q1 2021 | share | Decrease | -3.17% | -16.35K shares | -12.88M | $473.14 | 499.79K |
| Q4 2020 | share | Increase | +1.17% | 5.98K shares | -36.22M | $483.11 | 516.14K |
| Q3 2020 | share | Increase | +8.19% | 38.64K shares | -8.48M | $559.78 | 510.16K |
| Q2 2020 | share | Increase | +32.04% | 114.42K shares | 119.69M | $623.65 | 471.52K |
| Q1 2020 | share | Increase | +0.05% | 181 shares | 40.35M | $488.29 | 357.09K |
| Q4 2019 | share | Decrease | -3.46% | -12.78K shares | 31.46M | $375.48 | 356.91K |
| Q3 2019 | share | Decrease | -6.14% | -24.16K shares | -20.72M | $277.4 | 369.7K |
| Q2 2019 | share | Increase | +6.64% | 24.54K shares | -28.37M | $313 | 393.86K |
| Q1 2019 | share | Increase | +24.46% | 72.58K shares | 40.82M | $410.62 | 369.32K |
| Q4 2018 | share | Increase | 0.00% | 296.74K shares | 110.83M | $373.5 | 296.74K |
| Q3 2018 | share | Increase | +0.18% | 515 shares | 17.12M | $404.04 | 286.97K |
| Q2 2018 | share | Decrease | -3.57% | -10.61K shares | -3.47M | $344.99 | 286.45K |
| Q1 2018 | share | Increase | +4.40% | 12.51K shares | -4.68M | $344.36 | 297.07K |
| Q4 2017 | share | Increase | +5.93% | 15.92K shares | -13.13M | $375.96 | 284.56K |
| Q3 2017 | share | Increase | +9.60% | 23.53K shares | -268K | $447.12 | 268.64K |
| Q2 2017 | share | Increase | +6.50% | 14.96K shares | 31.19M | $491.14 | 245.11K |
| Q1 2017 | share | Increase | +5.72% | 12.44K shares | 9.26M | $387.51 | 230.14K |
| Q4 2016 | share | Increase | +4.37% | 9.11K shares | -3.94M | $367.09 | 217.70K |
| Q3 2016 | share | Decrease | -0.30% | -619 shares | 10.79M | $402.02 | 208.59K |
| Q2 2016 | share | Increase | +1.82% | 3.74K shares | -997K | $349.23 | 209.21K |
| Q1 2016 | share | Decrease | -5.84% | -12.74K shares | -44.40M | $360.44 | 205.46K |